Back to Search
NICHOLAS IRWIN, M.D.
M.D.
Emergency Medicine Physician
NPI: 1952694671IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Code: 390200000X
CMS Specialties
PrimaryEMERGENCY MEDICINE
Education
MEDICAL COLLEGE OF GEORGIA SCHOOL OF MEDICINE
Class of 2011
Research & Publications (20)
Active immunisation against gastric inhibitory polypeptide (GIP) improves blood glucose control in an animal model of obesity-diabetes.
PMID 18937625·Biol Chem·2009
7-preclinical
Prolonged GIP receptor activation using stable mini-PEGylated GIP improves glucose homeostasis and beta-cell function in age-related glucose intolerance.
PMID 19026698·Peptides·2009
7-preclinical
Antidiabetic effects of sub-chronic activation of the GIP receptor alone and in combination with background exendin-4 therapy in high fat fed mice.
PMID 19073224·Regul Pept·2009
7-preclinical
Fatty acid derivatised analogues of glucose-dependent insulinotropic polypeptide with improved antihyperglycaemic and insulinotropic properties.
PMID 19523458·Biochem Pharmacol·2009
7-preclinical
Inosine alters gene expression and axonal projections in neurons contralateral to a cortical infarct and improves skilled use of the impaired limb.
PMID 19553458·J Neurosci·2009
7-preclinical
Metabolic effects of sustained activation of the GLP-1 receptor alone and in combination with background GIP receptor antagonism in high fat-fed mice.
PMID 19515180·Diabetes Obes Metab·2009
4-observational
Evidence for beneficial effects of compromised gastric inhibitory polypeptide action in obesity-related diabetes and possible therapeutic implications.
PMID 19533083·Diabetologia·2009
6-review
Variation in phenotype, parasite load and male competitive ability across a cryptic hybrid zone.
PMID 19479073·PLoS One·2009
7-preclinical
Effects of gastric inhibitory polypeptide (GIP) and related analogues on glucagon release at normo- and hyperglycaemia in Wistar rats and isolated islets.
PMID 18163884·Biol Chem·2008
7-preclinical
Antidiabetic effects of sub-chronic administration of the cannabinoid receptor (CB1) antagonist, AM251, in obese diabetic (ob/ob) mice.
PMID 18191122·Eur J Pharmacol·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- UNIVERSITY OF KENTUCKY, 800 ROSE ST.
LEXINGTON, KY 40536 - Phone
- (859) 323-5083
Quick Facts
- NPI
- 1952694671
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 15
- Publications
- 20
Are you this provider?
Claim Your Profile